Interspecies scaling: Predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance

被引:80
作者
Mahmood, I [1 ]
Balian, JD [1 ]
机构
[1] US FDA,NEUROPHARMACOL DRUG PROD,ROCKVILLE,MD 20852
关键词
D O I
10.1021/js950400y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objective of this study was to test the interspecies-scaling approach in a series of antiepileptic drugs. Clearance, volume of distribution, and elimination half-life were scaled up from animal data obtained from literature. Four different methods were utilized to generate plots to scale up the clearance values: (i) clearance vs body weight (simple allometric equation); (ii) the product of clearance and maximum life-span potential (MLP) vs body weight (an approach recommended in literature); (iii) the two-term power equation which incorporates both body weight and brain weight suggested by Boxenbaum; and (iv) the product of clearance and brain weight vs body weight (a new approach being introduced in this study). When the predicted values for clearance were qualitatively compared with the observed values in humans, it was found that our proposed method predicted the clearance better than the other three methods. Using the simple allometric equation, the prediction of volume of distribution as a function of body weight was found to be satisfactory. The elimination half-life could not be predicted from simple allometric equations for any of the drugs studied; however, utilizing the equation CL = VK, prediction for half-life was feasible. The results of this study indicate that it is possible to predict reliably the pharmacokinetic parameters of these antiepileptic drugs in humans from animal data using an allometric approach.
引用
收藏
页码:411 / 414
页数:4
相关论文
共 24 条
[2]   COMPARATIVE PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS [J].
BIALER, M .
CLINICAL PHARMACOKINETICS, 1993, 24 (06) :441-452
[3]   SCALING OF ANTIPYRINE INTRINSIC CLEARANCE OF UNBOUND DRUG IN 15 MAMMALIAN-SPECIES [J].
BOXENBAUM, H ;
FERTIG, JB .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (02) :177-183
[4]   FIRST-TIME-IN-HUMAN DOSE SELECTION - ALLOMETRIC THOUGHTS AND PERSPECTIVES [J].
BOXENBAUM, H ;
DILEA, C .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (10) :957-966
[5]   INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1071-1121
[6]   INTERSPECIES VARIATION IN LIVER WEIGHT, HEPATIC BLOOD-FLOW, AND ANTIPYRINE INTRINSIC CLEARANCE - EXTRAPOLATION OF DATA TO BENZODIAZEPINES AND PHENYTOIN [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (02) :165-176
[7]   INTERSPECIES SCALING, ALLOMETRY, PHYSIOLOGICAL TIME, AND THE GROUND PLAN OF PHARMACOKINETICS [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02) :201-225
[8]   TIME CONCEPTS IN PHYSICS, BIOLOGY, AND PHARMACOKINETICS [J].
BOXENBAUM, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (11) :1053-1062
[9]  
BOXENBAUM H, 1985, PHARMACOKINETICS PHA, P93
[10]   INTERSPECIES SCALING OF TEBUFELONE PHARMACOKINETIC DATA AND APPLICATION TO PRECLINICAL TOXICOLOGY [J].
CRUZE, CA ;
KELM, GR ;
MEREDITH, MP .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :895-901